Skip to main content

Notable Upgrades: Esperion Therapeutics (ESPR), Rentrak (RENT), The Madison Square Garden Co. (MSG), Analog Devices (ADI), Valeant (VRX)

Analysts at Chardan Capital Markets are out with a report this morning upgrading shares of Esperion Therapeutics, Inc. (ESPR) with a ‘Neutral’ from ‘Sell’ rating. The firm however, lowered its price target for the company to $18 from $29. In the past 52 weeks, shares of Ann Arbor, Michigan-based biopharmaceutical company have traded between a low […] View the full post at: Notable Upgrades: Esperion Therapeutics (ESPR), Rentrak (RENT), The Madison Square Garden Co. (MSG), Analog Devices (ADI), Valeant (VRX) Related posts: Cablevision Plans to Spin Off Its Madison Square Garden Assets RF Semi Stocks Back in Institutional Favor – Upgrades for RF Micro Devices and TriQuint Semiconductor Forte to Buy Goldman’s Shanghai Garden Plaza for $200M
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.